Zobrazeno 1 - 10
of 272
pro vyhledávání: '"S. Eva Singletary"'
Publikováno v:
Aesthetic Surgery Journal. 30:821-831
Background: Given the 11% lifetime risk of breast cancer and increasing popularity of elective breast surgery, the role of preoperative screening begs further investigation. There are currently no guidelines that indicate which women younger than 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae55d05f4a6652392b667ca907bfe770
https://doi.org/10.1177/1090820x10386589
https://doi.org/10.1177/1090820x10386589
Autor:
S. Eva Singletary
Publikováno v:
Journal of the American College of Surgeons. 210:106-109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6115307211aeec379056f5942cd9ef0f
https://doi.org/10.1016/j.jamcollsurg.2009.10.004
https://doi.org/10.1016/j.jamcollsurg.2009.10.004
Autor:
Sato Ashida, Karen Basen-Engquist, Aunchalee E. L. Palmquist, S. Eva Singletary, Laura M. Koehly
Publikováno v:
The Gerontologist. 49:549-559
Purpose: This study evaluates the changes in social networks of older and younger breast cancer patients over a 6-month period following their fi rst diagnosis and how such modifi cations are associated with changes in the patients ’ mood state. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b44db1ac59460c43967fd42d728b9eb0
https://doi.org/10.1093/geront/gnp048
https://doi.org/10.1093/geront/gnp048
Autor:
S. Eva Singletary
Publikováno v:
Breast Diseases: A Year Book Quarterly. 20:18-21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4358a741acf468ea155f95caa54a3b
https://doi.org/10.1016/s1043-321x(09)79235-5
https://doi.org/10.1016/s1043-321x(09)79235-5
Autor:
Welela Terrefe, Tse Kuan Yu, Thomas A. Buchholz, Kelly K. Hunt, Gabriel N. Hortobagyi, D. Domain, S. Eva Singletary, Eric A. Strom, Wendy A. Woodward, George H. Perkins, Julia L. Oh, Massimo Cristofanilli, Aysegul A. Sahin, Ian J. Bristol
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 72:474-484
The aims of this study were to determine outcomes for patients with inflammatory breast cancer (IBC) treated with multimodality therapy, to identify factors associated with locoregional recurrence, and to determine which patients may benefit from rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a67d1063672001fd7b00624bf5f02e
https://doi.org/10.1016/j.ijrobp.2008.01.039
https://doi.org/10.1016/j.ijrobp.2008.01.039
Publikováno v:
Seminars in Oncology. 35:7-10
Inflammatory breast cancer (IBC) is an extremely aggressive disease that progresses rapidly and carries a very grim prognosis. It is characterized by erythema, rapid enlargement of the breast, skin ridging, and a characteristic peau d'orange appearan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bbca09a4f15d1c2c4deb9307cbe91b1
https://doi.org/10.1053/j.seminoncol.2007.11.010
https://doi.org/10.1053/j.seminoncol.2007.11.010
Autor:
S. Eva Singletary
Publikováno v:
Seminars in Oncology. 35:72-77
Multimodality therapy consisting of primary chemotherapy, mastectomy, and radiotherapy appears to offer the most favorable outcomes for patients with inflammatory breast carcinoma (IBC). Patients who respond well to chemotherapy are the best candidat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ad2df47ddfab99d59b4a92047642355
https://doi.org/10.1053/j.seminoncol.2007.11.008
https://doi.org/10.1053/j.seminoncol.2007.11.008
Autor:
Funda Meric-Bernstam, Ana M. Gonzalez-Angulo, Kristine Broglio, Massimo Cristofanilli, Aysegul A. Sahin, Sharon H. Giordano, Gabriel N. Hortobagyi, S. Eva Singletary, Thomas A. Buchholz, Bryan T. Hennessy, Aman U. Buzdar
Publikováno v:
The Oncologist. 12:904-912
The purpose of this study was to evaluate whether the survival of women with inflammatory breast cancer (IBC) treated at our institution has improved over the past 30 years. Three-hundred ninety-eight patients with IBC were treated between 1974 and 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dcf5e09351c98401817664ab0fd3025
https://doi.org/10.1634/theoncologist.12-8-904
https://doi.org/10.1634/theoncologist.12-8-904
Autor:
S. Eva Singletary, Lisa A. Newman
Publikováno v:
Surgical Clinics of North America. 87:499-509
The benefits of adjuvant systemic therapy in reducing risk of distant relapse from breast cancer have been recognized for several decades. The intent of adjuvant therapy is to eliminate the occult micrometastatic breast cancer burden before it progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4e7d7fc64657125cd33bb07d530f38
https://doi.org/10.1016/j.suc.2007.01.002
https://doi.org/10.1016/j.suc.2007.01.002
Autor:
S. Eva Singletary
Publikováno v:
Cancer. 109:1019-1029
The current paradigm of breast cancer management may be altered significantly over the coming years by the adoption of new treatment schema and devices outside of the surgical arena. New advances in breast cancer imaging will improve our ability to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40a6a7cb7ef699b458e5c1964e98d38b
https://doi.org/10.1002/cncr.22519
https://doi.org/10.1002/cncr.22519